The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy between Observational Studies and the Women's Health Initiative Clinical Trial
Abstract
Observational research on postmenopausal hormone therapy suggests a 40-50% reduction in coronary heart disease incidence among women using these preparations. In contrast, the Women's Health Initiative clinical trial of estrogen plus progestin found an elevated incidence over a 5.6-year intervention period through July 7, 2002. Toward explaining this discrepancy, the authors analyzed data from this trial, which included 16,608 postmenopausal women aged 50-79 years, and corresponding data from 53,054 women in the Women's Health Initiative observational study, 33% of whom were estrogen-plus-progestin users at baseline. Estrogen-plus-progestin hazard ratio estimates for coronary heart disease, stroke, and venous thromboembolism in the observational study were 39-48% lower than those in the clinical trial following age adjustment. However, hazard ratios tended to decrease with increasing time from initiation of estrogen-plus-progestin use, and observational study hazard ratio estimates are heavily weighted by longer-term use while clinical trial hazard ratio estimates reflect shorter-term use. Following control for time from estrogen-plus-progestin initiation and confounding, hazard ratio estimates were rather similar for the two cohorts, although there was evidence of some remaining difference for stroke. These analyses have implications for both the design and the analysis of observational studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
The rand 36‐item health survey 1.0
Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993) · Health Economics · doi:10.1002/hec.4730020305 · Cited by 2,884
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065 · cited 1×
“For coronary heart disease and venous thromboembolism, hazard ratios decrease with increasing time from estrogenplus-progestin initiation (6, 7, 30), so that overall hazard ratios in the observational study, which are heavily weighted by longer term estrogen-plus-progestin use, are less than those in the clinical tria…”
BackgroundEvaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646 · cited 1×
“For example, a cohort comprising new initiators of the study exposure (12) can be expected to yield meaningful average hazard ratio estimates over various periods of time from exposure initiation, even if a proportional hazards assumption is imposed.”
BackgroundStampfer, M. J., & Colditz, G. A. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90006-p · Cited by 1,600
Cited by
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
Wactawski-Wende, J., Kotchen, J. M., Anderson, G. L., Assaf, A. R., Brunner, R. L., O'Sullivan, M. J., Margolis, K. L., Ockene, J. K., Phillips, L., Pottern, L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055222 · Cited by 980
Self-citationCanonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M.-T., Wahl, D., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 864
Hernán, M. A., Alonso, A., Logan, R., Grodstein, F., Michels, K. B., Willett, W. C., Manson, J. E., & Robins, J. M. (2008) · Epidemiology · doi:10.1097/ede.0b013e3181875e61 · Cited by 818
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
(2012) · Menopause · doi:10.1097/gme.0b013e31824b970a · Cited by 785
Evidence for Health Decision Making — Beyond Randomized, Controlled Trials
Frieden, T. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1614394 · Cited by 770
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
Menopause and cardiovascular disease: the evidence
Rosano, G. M. C., Vitale, C., Marazzi, G., & Volterrani, M. (2007) · Climacteric · doi:10.1080/13697130601114917 · Cited by 470
Fixed effects analysis of repeated measures data
Gunasekara, F. I., Richardson, K., Carter, K., & Blakely, T. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt221 · Cited by 424
Big Data and Large Sample Size: A Cautionary Note on the Potential for Bias
Kaplan, R. M., Chambers, D. A., & Glasgow, R. E. (2014) · Clinical and Translational Science · doi:10.1111/cts.12178 · Cited by 421
On regression adjustments to experimental data
Freedman, D. A. (2008) · Advances in Applied Mathematics · doi:10.1016/j.aam.2006.12.003 · Cited by 417
The Consistency Statement in Causal Inference: A Definition or an Assumption?
Cole, S. R., & Frangakis, C. E. (2009) · Epidemiology · doi:10.1097/ede.0b013e31818ef366 · Cited by 413
Making Americans healthier: social and economic policy as health policy
(2009) · Choice Reviews Online · doi:10.5860/choice.46-5680 · Cited by 409
Spontaneous Coronary Artery Dissection Associated With Pregnancy
Tweet, M. S., Hayes, S. N., Codsi, E., Gulati, R., Rose, C. H., & Best, P. J. M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.055 · Cited by 355
Maximum Likelihood Estimation in Semiparametric Regression Models with Censored Data
Zeng, D., & Lin, D. Y. (2007) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1369-7412.2007.00606.x · Cited by 315
Observational research--opportunities and limitations
Boyko, E. J. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.07.007 · Cited by 313
Stürmer, T., Wyss, R., Glynn, R. J., & Brookhart, M. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12197 · Cited by 302
Prentice, R. L., Pettinger, M. B., Jackson, R. D., Wactawski-Wende, J., LaCroix, A. Z., Anderson, G. L., Chlebowski, R. T., Manson, J. E., Van Horn, L., Vitolins, M. Z., et al. (2013) · Osteoporosis International · doi:10.1007/s00198-012-2224-2 · Cited by 295
Self-citationA Review of Generalizability and Transportability
Degtiar, I., & Rose, S. (2023) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-042522-103837 · Cited by 295
Middle Cerebral Artery Occlusion Model in Rodents: Methods and Potential Pitfalls
Liu, F., & McCullough, L. D. (2011) · BioMed Research International · doi:10.1155/2011/464701 · Cited by 254
Hodis, H. N., & Mack, W. J. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.076 · Cited by 83
Vandenbroucke, J., & Pearce, N. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv225 · Cited by 67
“Although limiting the analysis to persons followed from first exposure onward solved this problem in 1 study (29), an analysis by duration of exposure (time since first exposure) (28) addressed the problem equally well and showed essentially the same findings (36).”
BackgroundRoehm, E. (2015) · Obstetrics and Gynecology International · doi:10.1155/2015/713295 · Cited by 22
“(This can be determined by the previously reportedmean age of menopause of trial participants [16, 17] in conjunction with published data on the number of years frommenopause at time of starting initial prior course of hormone therapy [18].”
ResultInfluence of menopausal hormone therapy on body composition and metabolic parameters
Costa, G. B. C., Carneiro, G., Umeda, L., Pardini, D., & Zanella, M. T. (2020) · BioResearch Open Access · doi:10.1089/biores.2019.0050 · Cited by 17
Metadata
- Authors
- Prentice, R. L., Langer, R., Stefanick, M. L., Howard, B. V., Pettinger, M., Anderson, G., Barad, D., Curb, J. D., Kotchen, J., Kuller, L., Limacher, M., & Wactawski-Wende, J.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 162
- Issue
- 5
- Pages
- 404-414
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2168512925
- Cited by
- 264
- References
- 56
- FWCI
- 16.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.